Astellas Pharma Market Cap

Astellas Pharma has a market cap or net worth of 2.42 trillion as of April 17, 2025. Its market cap has decreased by -19.36% in one year.

Market Cap

2.42T

Enterprise Value

3.16T

Revenue

1.87T

Ranking

n/a

PE Ratio

n/a

Stock Price

1,352.50

Market Cap Chart

Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 2.42T, an increase of 174.24%. That is a compound annual growth rate of 3.08%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2025	2,421.12B	-11.86%
Dec 30, 2024	2,746.92B	-9.13%
Dec 29, 2023	3,022.77B	-17.34%
Dec 30, 2022	3,657.07B	5.52%
Dec 30, 2021	3,465.82B	17.06%
Dec 30, 2020	2,960.81B	-15.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	11.11T
Takeda Pharmaceutical Company	6,408.60B
Daiichi Sankyo Company	5,864.41B
HOYA Corporation	5,249.13B
Terumo	3,869.45B
Otsuka Holdings	3,536.35B
Olympus	1,994.44B
Shionogi &	1,976.14B

Market Cap Rankings